Penetration of isavuconazole into the epithelial lining fluid of patients with pulmonary fungal infections. Comment on: 'Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions'

J Antimicrob Chemother. 2024 Sep 3;79(9):2403-2405. doi: 10.1093/jac/dkae258.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antifungal Agents* / administration & dosage
  • Antifungal Agents* / pharmacokinetics
  • Healthy Volunteers
  • Humans
  • Infusions, Intravenous
  • Lung Diseases, Fungal / drug therapy
  • Nitriles* / administration & dosage
  • Nitriles* / pharmacokinetics
  • Pyridines* / administration & dosage
  • Pyridines* / pharmacokinetics
  • Triazoles* / administration & dosage
  • Triazoles* / pharmacokinetics

Substances

  • isavuconazole
  • Triazoles
  • Antifungal Agents
  • Pyridines
  • Nitriles